General representation. Regulations and legislation relating to PBMs and drug pricing. Issues related to the 340B drug discount program
2026 · 1st Quarter (Jan 1 - Mar 31)
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Filed by FARRAGUT PARTNERS LLP.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 20, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- FARRAGUT PARTNERS LLP
- Filing UUID
- a0d11795-e9a6-4a81-82eb-ef7492787849
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.